| 2021-07-07 | OYLER JOHN | Chief Executive Officer | Sell | 59,732 | $102.70 | $6,134,715.29 | -0.9% | → |
| 2021-07-06 | Wu Xiaobin | President, COO & GM China | Sell | 10,180 | $325.53 | $3,313,926.81 | -26.3% | → |
| 2021-07-01 | Wang Xiaodong | - | Sell | 4,848 | $348.15 | $1,687,852.35 | -26.4% | → |
| 2021-07-01 | Wang Julia Aijun | Chief Financial Officer | Sell | 308 | $349.06 | $107,511.68 | -100% | → |
| 2021-06-29 | Huang Jane | CMO, Hematology | Sale+OE | 1,925 | $354.97 | $683,323.00 | -34.2% | → |
| 2021-06-28 | Wang Lai | Global Head of R&D | Sell | 455 | $362.48 | $164,929.95 | -100% | → |
| 2021-06-28 | Liang Howard | CFO & Chief Strategy Officer | Sell | 446 | $365.00 | $162,790.00 | -100% | → |
| 2021-06-18 | Liang Howard | CFO & Chief Strategy Officer | Sell | 486 | $325.89 | $158,383.46 | -100% | → |
| 2021-06-18 | Wu Xiaobin | President, COO & GM China | Sell | 1,156 | $330.93 | $382,550.57 | -100% | → |
| 2021-06-18 | Wang Lai | Global Head of R&D | Sell | 802 | $331.15 | $265,583.18 | -100% | → |
| 2021-06-18 | Huang Jane | CMO, Hematology | Sell | 469 | $325.66 | $152,733.04 | -100% | → |
| 2021-06-10 | Chen Timothy Yung-Cheng | - | Sale+OE | 6,000 | $351.67 | $2,110,017.89 | -48.0% | → |
| 2021-06-07 | Wu Xiaobin | President, COO & GM China | Sell | 2,825 | $352.33 | $995,326.04 | -83.1% | → |